Latest Earnings Analysis
-
Celanese (CE) Q2 2025: Western Hemisphere Volumes Drop to 20-Year Lows, Forcing Deeper Cost Action
August 12, 2025 · CE
-
PennantPark Floating Rate Capital (PFLT) Q3 2025: New $500M JV Signals 12-18 Month Deployment Ramp
August 12, 2025 · PFLT
-
KBDC Q2 2025: Broadly Syndicated Loan Book Falls Below $80M as Private Credit Rotation Accelerates
August 12, 2025 · KBDC
-
Net Power (NPWR) Q2 2025: Project Permian LCOE Falls Below $100, Unlocking Sequencing Upside
August 12, 2025 · NPWR
-
Anavex Life Sciences (AVXL) Q3 2025: $101M Cash Runway Extends Over 3 Years as EMA Decision Nears
August 12, 2025 · AVXL
-
Tencent Music (TME) Q2 2025: Subscription Revenue Jumps 17% as SVIP Base Surpasses 15M
August 12, 2025 · TME
-
Eagle Point Income (EIC) Q2 2025: $6.5M Buyback at 6.4% Discount Signals Capital Deployment Shift
August 12, 2025 · EIC
-
SoundPoint Meridian Capital (SPMC) Q1 2025: 49% of CLO Portfolio Eligible for Refinancing, Pivots Toward Liability Cost Recovery
August 12, 2025 · SPMC
-
Consolidated Water (CWCO) Q2 2025: Manufacturing Jumps 33% as Capacity Expansion Targets Nuclear and Municipal Growth
August 12, 2025 · CWCO
-
Broadwind (BWEN) Q2 2025: Industrial Solutions Orders Triple, $13M Asset Sale Reshapes Portfolio
August 12, 2025 · BWEN
-
IHS (IHS) Q2 2025: Net Leverage Falls to 3.4x as Debt Repayment and Margin Discipline Accelerate Capital Return Path
August 12, 2025 · IHS
-
Valneva (VALN) Q2 2025: Product Sales Jump 33% as Lyme Vaccine Milestone Nears
August 12, 2025 · VALN
-
eToro (ETOR) Q2 2025: Net Contribution Climbs 26% as Tokenized Asset Push and AI Tools Expand Platform Reach
August 12, 2025 · ETOR
-
Arc Restaurants (ARKR) Q3 2025: $4.7M Sequoia Impairment Highlights Market Headwinds, Casino Optionality Emerges
August 12, 2025 · ARKR
-
Infinity Natural Resources (INR) Q2 2025: Production Jumps 25% as Marcellus Gas Drives Operating Leverage
August 12, 2025 · INR
-
HighPeak Energy (HPK) Q2 2025: Simulfrac Drives 10% Completion Cost Savings as CapEx Drops 30%
August 12, 2025 · HPK
-
Madison Square Garden Sports (MSGS) Q4 2025: Local Rights Fees Cut 28% for Knicks, Shifting Media Revenue Mix
August 12, 2025 · MSGS
-
KOPN Q2 2025: $15M Theon Investment Reshapes Global Defense Playbook
August 12, 2025 · KOPN
-
Nauticus Robotics (KITT) Q2 2025: Service Revenue Quadruples, Asset Utilization Drives Margin Visibility
August 12, 2025 · KITT
-
U.S. Energy (USEG) Q2 2025: Montana Resource Confirmed at 444 Bcf CO2, Unlocking Multi-Stream Monetization
August 12, 2025 · USEG
-
ARC (ARQ) Q2 2025: GAC Line Commissioned, Unlocking 25M Pound Capacity for High-Margin Expansion
August 12, 2025 · ARQ
-
Taysha (TSHA) Q2 2025: $230M Raise Extends Runway, Pivotal Rett Trial Site Activation Signals Regulatory Momentum
August 12, 2025 · TSHA
-
Autolus (AUTL) Q2 2025: 46 U.S. Centers Activated, Setting Stage for Broad OB-Cell Uptake
August 12, 2025 · AUTL
-
ADC Therapeutics (ADCT) Q2 2025: Lotus 7 Delivers 87% Complete Response Rate, Reshaping DLBCL Market Path
August 12, 2025 · ADCT
-
Nano-X (NNOX) Q2 2025: 20+ Active Systems Drive U.S. Imaging Revenue Expansion
August 12, 2025 · NNOX
-
Hillenbrand (HI) Q3 2025: $380M Debt Reduction Sharpens Focus on High-Margin Segments
August 12, 2025 · HI
-
ONON (ONON) Q2 2025: DTC Mix Hits 41%, Accelerating Premium Margin Expansion
August 12, 2025 · ONON
-
HUYA (HUYA) Q2 2025: Game-Related Revenue Jumps 34%, Reshaping Growth Mix
August 12, 2025 · HUYA
-
TAT Technologies (TATT) Q2 2025: Backlog Jumps $85M as Margin Expansion Signals Durable Outperformance
August 12, 2025 · TATT
-
ECC Q2 2025: Reset Pipeline and $86M Deployments Offset 50bps Loan Spread Compression
August 12, 2025 · ECC
-
Bitcoin Depot (BTM) Q2 2025: Gross Margin Jumps 360bps as Kiosk Optimization Drives Profitability
August 12, 2025 · BTM
-
Pony AI (PONY) Q2 2025: Robotaxi Fare Revenue Surges 300% as Gen 7 Scale Drives Unit Cost Down
August 12, 2025 · PONY
-
Smithfield Foods (SFD) Q2 2025: Hog Production Profit Outlook Raised by $50M as Margin Initiatives Gain Traction
August 12, 2025 · SFD
-
3D Systems (DDD) Q2 2025: $85M Cost Program Targets Positive Cash Flow as MedTech Grows 13%
August 12, 2025 · DDD
-
Hydrofarm (HYFM) Q2 2025: SKU Rationalization Cuts 33% of Portfolio, Targeting $3M+ Annual Savings
August 12, 2025 · HYFM
-
Aquestive Therapeutics (AQST) Q2 2025: Pre-Launch Spend Rises $4.2M as Anafilm Nears FDA Decision
August 12, 2025 · AQST
-
ChipMOS (IMOS) Q2 2025: Memory Revenue Jumps 21% as DDIC Weakness and FX Drag Margin
August 12, 2025 · IMOS
-
Harrow (HROW) Q2 2025: TriEssence Up 32% as Ophthalmic Portfolio Accelerates Leverage
August 12, 2025 · HROW
-
NGS (NGS) Q2 2025: Growth CapEx Surges to 140% of EBITDA, Outpacing Peers and Fueling Share Gains
August 12, 2025 · NGS
-
CMP Q3 2025: Plant Nutrition Margins Jump 23% as Back-to-Basics Strategy Drives Cost Reset
August 12, 2025 · CMP
-
NeurAxis (NRXS) Q2 2025: 46% Revenue Growth Sets Stage for CPT Code-Driven Inflection
August 12, 2025 · NRXS
-
Fluence Energy (FLNC) Q3 2025: $4.9B Backlog Anchors Post-Tariff U.S. Recovery
August 12, 2025 · FLNC
-
Cardinal Health (CAH) Q4 2025: Specialty Alliance Adds $1.5B Revenue, Fueling Double-Digit EPS Guidance Raise
August 12, 2025 · CAH
-
Paysafe (PSFE) Q2 2025: Enterprise Contract Value Up 20%, Fueling Back-Half Growth Visibility
August 12, 2025 · PSFE
-
Altimmune (ALT) Q2 2025: $183M Cash Bolsters Phase 3 MASH Readiness Amid 59% Resolution Signal
August 12, 2025 · ALT
-
Liquidia (LQDA) Q2 2025: Eutrepia Prescriptions Top 900 in 11 Weeks, Accelerating Prostacyclin Market Disruption
August 12, 2025 · LQDA
-
XTNT Q2 2025: $19M Asset Sale Refocuses Portfolio, Biologics Growth Hits 20%
August 12, 2025 · XTNT
-
Acumen Pharmaceuticals (ABOS) Q2 2025: $166M Cash Runway Extends to 2027 as EBD Pipeline Advances
August 12, 2025 · ABOS
-
Sea Ltd (SE) Q2 2025: Shopee GMV Jumps 28% as Profitability Expands Across All Businesses
August 12, 2025 · SE
-
Chipmos (HMR) Q2 2025: Memory Revenue Jumps 21%, Offsetting DDIC and FX Margin Strain
August 12, 2025 · HMR